Kieran Phillips 🔎’s Post

“Eko Health, the California-based healthcare technology company known for its advanced stethoscopes, has received U.S. Food and Drug Administration (FDA) approval for a new artificial intelligence (AI) offering designed to detect low ejection fraction (EF). The newly approved algorithm is designed to work in just 15 seconds; it automatically runs when users conduct routine physicals with one of Eko Health’s stethoscopes. Eko Health developed this AI offering with heart failure in mind. By getting the technology in the hands of physicians, the company hopes symptomatic patients can be identified earlier than normal, improving their chances of receiving the care they need. Low Ejection Fraction AI is the latest addition to Eko Health’s Sensora Cardiac Early Detection Platform. It joins other FDA-approved algorithms for identifying signs of atrial fibrillation and structural heart murmurs.” American Heart Association MedTech Innovator MedTech Strategist Heart Rhythm Society #epeeps American College of Cardiology

This recent study, conducted at The Ohio State University Wexner Medical Center and presented at #USCAP2024, showed high performance for Galen Gastric in identifying various benign, dysplastic and malignant gastric mucosal lesions in a fully digitized #pathology laboratory setting. Investigators concluded that the #AI solution showed potential to triage the critical cases, increase accuracy, and provide more efficient workflows, potentially leading to improved patient care. Learn more: https://lnkd.in/eeQ3MMiz Giovanni Lujan MD, Anil Parwani, Zaibo Li, Himani Kumar, David Kellough, Martha Milanes-Yearsley, Nada Shaker The Ohio State University #digitalpathology #gastriccancer

🔍 Discover more about the RANO imaging criteria in clinical trials and particularly for glioblastomas by reading our blog post written by Pierre Tervé, CSO at Keosys. #MedicalImaging #ClinicalTrial #Glioblastoma

Digital twins could revolutionize arrhythmia care, enabling personalized medicine. But the path forward requires collaboration to overcome challenges. Our new review with Gernot Plank and Jordi H. lays out the promise and critical next steps: https://lnkd.in/eWwYkVNE Digital twins integrate modeling, personalization, and clinical application to potentially transform arrhythmia management into truly personalized medicine. While successful examples like virtual FFR exist, significant challenges remain in electrophysiology. Our review discusses these challenges, including improving modeling reproducibility and validation, advancing personalization of structural and electrophysiological properties, and demonstrating the clinical benefit of digital twin-guided care. Despite the hurdles, we believe digital twins have immense potential in arrhythmia ablation guidance and risk stratification. Realizing this vision will require close collaboration between clinicians, modelers, and industry. #DigitalTwin #PersonalizedMedicine #Electrophysiology #Arrhythmia

Did you know that about 2 out of 3 episodes of deep vein thrombosis (DVT) are clinically silent? And that a very significant proportion of such DVT episodes result in pulmonary embolism, which can be life-threatening if not detected quickly? Developing novel tools to facilitate early diagnosis and treatment is key to substantially reducing serious or fatal outcomes.   Last week our colleagues Lucas and Frans participated in the second physical meeting of the ThrombUS+ Horizon EU Project in Kaunas, Lithuania. The project aims to develop a wearable solution for continuous and point-of-care DVT screening, based on the innovative combination of real-time imaging and AI technologies.    PredictBy is leading the work of integrating clinical, technical and regulatory needs into a useful and acceptable device design for patients.   Find more about the project's partners and milestones at ⬇ https://lnkd.in/dny3Zepn   #DVT #thrombosis #HorizonEU #EarlyDetection #MedTech

What’s the difference between a fixed output and a closed-loop SCS system? And why does it matter? It all comes down to the patient's need for consistent therapy. Find out how the Inceptiv™ Spinal Cord Stimulator (SCS) with closed-loop technology senses† neural signals and automatically responds in real time so that patients have a seamless experience during all their activities. No wonder patients prefer Inceptiv™ SCS closed-loop algorithm over fixed-output stimulation; it's preferred by 9 out of 10 patients.(1) See risk information: https://bit.ly/3QLF00e Go to Medtronic.com/Inceptiv or talk to your Medtronic Representative to learn more about why Inceptiv™ SCS system is the most advanced SCS system with closed-loop technology. #MDTPainInterventional #PatientFirst #InceptivSCS #ClosedLoopTechnology #MedtronicSCS #ClosedLoop #SCS #SpinalCordStimulation #ECAP #MRIAccess 1.ECHO MAC Final Clinical Study Report V1.0 2021.08.18 †Sensing signals may not be measurable in all cases.

🌊 Microbubble Technology: A Game-Changer in Medical Diagnostics and Therapy 🌊 Microbubble technology is transforming diagnostics and therapeutic interventions in healthcare. These minuscule, gas-filled bubbles are already significantly improving ultrasound imaging by providing better contrast and more precise diagnoses. Beyond imaging, their ability to deliver targeted drugs is reshaping treatments for diseases such as cancer, cardiovascular conditions, and others. With ongoing research, the use of microbubbles in medicine promises safer, more accurate, and minimally invasive solutions for patients around the globe. Exciting advancements lie ahead for this remarkable technology! #MicrobubbleTechnology #MedicalInnovation #UltrasoundImaging #TargetedTherapies #BiomedicalEngineering #HealthcareTechnology #NonInvasiveTherapy #DrugDeliverySystems #FutureOfHealthcare

Is it important that radiologists know clinical information in axSpA patients? Our latest research delves into how #clinical insights significantly boost the #accuracy and #specificity of #sacroiliac joint imaging for #axialspondyloarthritis diagnosis. The findings reveal that incorporating patient clinical profiles not only sharpens diagnostic precision but also bolsters radiologists' confidence. This emphasizes the crucial role of merging clinical data with #imaging assessments in enhancing diagnosis. Yes, it indeed makes a difference. Dive deeper into the study here: https://lnkd.in/ezGe_NrX

Read more about the ThrombUS+ project and its significance from one of the consortium partners:

Safety is undoubtedly one of the key factors in radiotherapy 🔒, and at RaySearch Laboratories, we understand that.    This is why we are developing:   🔹 RayCare®* as a trusted ally, securely🔒 guiding you through the entire patient treatment journey. It coordinates care with precision, leaving nothing to chance.  🔹 RayStation®* as a comprehensive software that integrates all treatment planning tools in one place, ensuring🔒 seamless focus without the need to switch between systems.  🔹 RayIntelligence® as a support system for oncology analytics that enables data-driven clinical decisions to maintain the highest level of safety🔒.    This commitment to safety is also why we decided to sponsor an episode of the Physics World Weekly podcast 🎧, exploring the vital role of medical physicists in keeping patients safe during healthcare procedures.    It is our pleasure to share this important knowledge - undoubtedly. https://lnkd.in/e3pxmhAM    #RaySearch #RayStation #RayCare #RayIntelligence    *Subject to regulatory clearance in some markets.